EKSO

#4426
Ekso Bionics Holdings, Inc. Common Stock
11.3700 USD
+1.70%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
11.3700
11.3700
Rango anual
7.8900
13.5000
Cambio diario
+1.70%
Variación mensual
+13.59%
Variación en los últimos 6 meses
-9.19%
Cambio anual
-9.19%
Cierres anteriores
11.1800
Abrir
11.3700
Mínimo
11.3700
High
11.3700
Volumen
1
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
Informe de resultados Saldo Flujo de caja
Valor 202020212022202320242025 TTM

Ekso Bionics Holdings Inc

Ekso Bionics Holdings Inc. is a company that develops and manufactures powered exoskeleton bionic devices that can be strapped on as wearable robots to enhance the strength, mobility, and endurance of industrial workers and people experiencing paralysis and mobility issues after a brain injury, stroke, multiple sclerosis or spinal cord injury. They enable individuals with any amount of lower extremity weakness, including those who are paralyzed, to stand up and walk. Ekso Bionics currently focuses in the health and industrial sectors. The company's first commercially available health product was called EksoGT. Ekso Bionics is the original developer of HULC, now under military development by Lockheed Martin, and the current developers of EksoNR, which allows patients who are relearning to walk the ability to stand and take steps. In December 2022, Ekso Bionics acquired the Human Motion & Control business unit from Parker Hannifin which includes the Indego product line. This acquisition allowed Ekso Bionics to begin selling exoskeletons to those who have an SCI and want a personal exoskeleton to walk at home and in their community.

Noticias